Tarsus to Participate in Upcoming Investor Conferences
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in fireside chats at two ...
Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Up 9% Following Analyst Upgrade
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) was up 9% during trading on Monday after Barclays raised their ...
Tarsus Pharmaceuticals (NASDAQ:TARS) Given New $62.00 Price Target at Barclays
Tarsus Pharmaceuticals (NASDAQ:TARS – Get Free Report) had its price objective lifted by equities researchers at Barclays ...
Oppenheimer lifts Tarsus stock target, impressed by execution and ocular rosacea potential
Oppenheimer updated its outlook on Tarsus Pharmaceuticals (NASDAQ:TARS), a $1.8 billion market cap biotechnology company, ...
Tarsus: Promising Investment, But Timing Is The Key
Tarsus Pharmaceuticals' lotilaner shows strong market performance for Demodex blepharitis, but cautious investment due to ...
Tarsus Pharmaceuticals reshuffles board, appoints new committee chair
IRVINE, CA – Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), a $1.78 billion market cap company specializing in biological ...
A Glimpse Into The Expert Outlook On Tarsus Pharmaceuticals Through 4 Analysts
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $60.0, a high ...
Htxt.Africa3d
Tarsus brings Darktrace self-learning AI security to Africa
Local technology distributor Tarsus Distribution has announced that it will be bring the Self-Learning AI technology from ...
The Most Common Eyelid Disease You’ve Never Heard of Is Caused by Tiny Mites
Dealing with red, itchy eyelids? The culprit could be a common mite. This article is sponsored by XDEMVY. Dr. Watson is a ...
Tech Financials on MSN3d
Tarsus Distribution Partners With Darktrace To Boost Africa’s Cybersecurity With AI
Tarsus Distribution has joined forces with Darktrace, a global leader in AI for cybersecurity, to bring enhanced cybersecurity solutions to Africa. This partnership will leverage the existing ...
Tarsus制药重组董事会，任命新委员会主席
加利福尼亚州尔湾市 - 市值17.8亿美元的生物制品公司Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)根据最近向美国证券交易委员会提交的8-K文件，宣布了董事会成员和委员会任命的变更。
Oppenheimer上调Tarsus股票目标价，对执行力和眼部玫瑰痤疮潜力印象深刻
Oppenheimer分析师Francois Brisebois解释了上调目标价的理由。评论重点关注了Tarsus Pharmaceuticals的产品XDEMVY的令人印象深刻的销售数据，特别强调了其在治疗眼部玫瑰痤疮方面的潜力。该公司展现了显著的增长，InvestingPro数据显示，过去十二个月的收入增长率高达802%。